** Shares of health insurer Cigna CI.N rise 1.7% to $340.70 premarket
** Co raises full-year earnings forecast and beats estimates for quarterly profit on strong performance in its pharmacy benefit management business and lower-than-expected medical costs in its insurance arm
** Co forecasts 2025 adj. profit of at least $29.60 per share vs previous estimate of $29.50 and analysts' estimate of $29.61, as per data compiled by LSEG
** Co reports Q1 adj. income from operations of $6.74, above estimates of $6.35
** Co's Q1 medical care ratio - the percentage of premiums spent on medical care, came in at 82.2%, lower than analysts' estimates of 82.63%
** "At first glance, Cigna rebounded from a challenging Q4 to post a strong Q1 beat. Although the guidance raise was modest relative to the beat, this could reflect some early-year conservatism"- brokerage Oppenheimer
** Up to last close, stock was up 21.4% YTD
(Reporting by Sneha S K)
((Sneha.SK@thomsonreuters.com))
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。